Advertisement

Medizinische Klinik

, Volume 94, Issue 6, pp 329–337 | Cite as

Gastrointestinale Komplikationen des Diabetes mellitus

  • Michael Vogt
  • Henning E. Adamek
  • Joachim C. Arnold
  • Dieter Schilling
  • Thomas Schleiffer
  • Jürgen F. Riemann
Übersicht
  • 42 Downloads

Zusammenfassung

□ Hintergrund

Der Diabetes mellitus führt zu einem großem Spektrum von Symptomen und Organmanifestationen im Bereich, des Verdauungssystems.

□ Grundlagen

Die Pathophysiologie, diagnostischen Strategien und die zahlreichen Differentialdiagnosen dieser Folgeerkrankungen, die unter dem Begriff der diabetischen Enteropathie zusammengefaßt werden können, werden eingehend dargestellt.

□ Klinik

Einen großen Raum nehmen hierbei die Motilitätsstörungen des Intestinums und deren Behandlung ein. Klinisch bedeutsam sind die Motilitätsstörungen vor allem in Form einer verzögerten Magenentleerung und der Obstipation. Diabetiker neigen außerdem zu infektiösen Komplikationen, möglicherweise zur Ausbildung bestimmter Neoplasien und weiterer Folgeerkrankungen, die in organbezogener Reihenfolge besprochen werden. Hierbei werden die mit einem Diabetes mellitus assoziierten Erkrankungen des Magens, der Leber, der Gallenblase, des Pankreas und des Darms berücksichtigt.

□ Schlußfolgerung

Die neuen diagnostischen und therapeutischen Strategien erfordern eine enge Kooperation der klinischen Fächer, um intestinalen Folgeerkrankungen des Diabetes mellitus vorzubeugen oder diese erfolgreich zu therapieren.

Schlüsselwörter

Diabetische Enteropathie Intestinale Motilitätsstörungen Diagnose Therapie 

Gastrointestinal complications in patients with diabetes mellitus

Abstract

□ Background

Diabetes mellitus leads to a broad spectrum of symptoms and manifestations in the field of gastroenterology.

□ Basis

This article reviews the pathophysiology, differential diagnoses and secondary diseases of the gastrointestinal tract in diabetic patients.

□ Clinical Appearance

Motility disorders, infectious complications, secondary diseases of the stomach, liver, pancreas, gall bladder, small and large bowel are considered and discussed. Diagnostic and therapeutic approaches for the management of diabetic enteropathy are presented.

□ Conclusion

The new strategies in diagnosis and therapy for a successfull prevention or treatment of gastrointestinal complications due to diabetes mellitus need good cooperation of clinical specialities.

Key Words

Secondary diseases of diabetes mellitus Diabetic enteropathy Motility disorders Therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Acerini CL, Ahmed ML, Ross RM, et al. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med 1998;15:38–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307–14.PubMedCrossRefGoogle Scholar
  3. 3.
    Ahn YH, Maturu P, Steinheber FU, et al. Association of diabetes mellitus with gastric bezoar formation. Arch Intern Med 1987;147:527–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Altmann DM, Sansom D, Marsh SG. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 1991;12:267–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Aly FZ, Blackwell CC, McKenzie DA, et al. Identification of oral yeast species isolated from individuals with diabetes mellitus. Mycoses 1995;38:107–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Arnold R, Frank M: Endokrine Pankreastumoren. In: Hahn EG, Riemann JF, Hrsg. Klinische Gastroenterologie. Stuttgart-New York: Thieme, 1996:1199.Google Scholar
  7. 7.
    Barbara L, Sama C, Labate AMM, et al. A population study on the prevalence of gall stone disease: the sirmione study. Hepatology 1987;7:913–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Barera G, Bianchi C, Calisti L, et al. Screening of diabetic children for celiac disease with antigliadin antibodies and HLA typing. Arch Dis Child 1991;66:491–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Belai A, Lefebvre RA, Burnstock G. Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats. Eur J Pharmacol 1991;194:225–34.PubMedCrossRefGoogle Scholar
  10. 10.
    Benz C, Riemann JF. Störungen der Motilität. In: Hahn EG, Riemann JF, Hrsg. Klinische Gastroenterologie, Bd I, Stuttgart-New York: Thieme, 1996:532–46.Google Scholar
  11. 11.
    Brugge WR. Motor function of the gallbladder: measurement and clinical significance. Semin Roentgenol 1991;26:226–31.PubMedCrossRefGoogle Scholar
  12. 12.
    Burchfiel CM, Sharp DS, Curb JD, et al. Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol 1995;141:360–8.PubMedGoogle Scholar
  13. 13.
    Catnach SM, Ballinger AB, Stevens M, et al. Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy. Gut 1993;34:1123–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Chapman BA, Wilson IR, Frampton CM, et al. Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci 1996;41:2222–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Chapman BA, Burt MJ, Chisholm RJ, et al. Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor. Dig Dis Sci 1998;43:349–53.PubMedCrossRefGoogle Scholar
  16. 16.
    Chedin P, Cahen-Varsaux J, Boyer N. Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C. Ann Intern Med 1996;125:521–4.PubMedGoogle Scholar
  17. 17.
    Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989;84:868–72.PubMedGoogle Scholar
  18. 18.
    Colford JM Jr, Mohle-Boetani J, Vosti KL. Group B streptococcal bacteremia in adults. Five years’ experience and a review of the literature. Medicine (Baltimore) 1995;74:176–90.CrossRefGoogle Scholar
  19. 19.
    Collins RW, Anderson JW. Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women. Prev Med 1995;24:369–74.PubMedCrossRefGoogle Scholar
  20. 20.
    Conte D, Manachino D, Colli A, et al. Prevalence, of genetic hemochromatosis in a cohort of italian patients with diabetes mellitus. Ann Intern Med 1998;128:370–3.PubMedGoogle Scholar
  21. 21.
    Cronin CC, Feighery A, Ferris JB, et al. High prevalence of celiac disease among patients with insulin dependent (type I) diabetes mellitus. Am J Gastroenterol 1997; 92:2210–2.PubMedGoogle Scholar
  22. 22.
    Czink E, Tamas G. Screening for idiopathic hemochromatosis among diabetic patients. Diabetes Care 1991; 14:929–30.PubMedGoogle Scholar
  23. 23.
    Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group (see comments). N Engl J Med 1996;335:547–54.PubMedCrossRefGoogle Scholar
  24. 24.
    de Boer SY, Masclee AA, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994;37:75–81.PubMedCrossRefGoogle Scholar
  25. 25.
    Del-Favero G, Caroli T, Meggiato A et al. Natural history of gallstones in non-insulin-dependent diabetes mellitus. A prospective 5-year follow-up. Dig Dis Sci 1994;39:1704–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Dorlars D, D Schilling, Riemann JF. Möglichkeiten der Sonographie bei der Beurteilung von Magenmotilitätsstörungen. Dtsch Med Wochenschr 1994;119:575–80.PubMedCrossRefGoogle Scholar
  27. 27.
    Duchen LW, Anjorin A, Watkins PJ, et al. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980;92:301–3.PubMedGoogle Scholar
  28. 28.
    Eliasson B, Bjornsson E, Urbanavicius V, et al. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption. Diabetologia 1995;38:79–85.PubMedCrossRefGoogle Scholar
  29. 29.
    Ernährungsbedingte Krankheiten und ihre Kosten. Schriftenreihe des Bundesministeriums für Gesundheit, Bd 27. Baden-Baden: Nomos, 1993.Google Scholar
  30. 30.
    Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis JAMA 1995;273: 1605–9.Google Scholar
  31. 31.
    Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci 1996;41:1–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann intern Med 1985; 102:197–9.PubMedGoogle Scholar
  33. 33.
    Feldman M, Schiller ER. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983;98:378–84.PubMedGoogle Scholar
  34. 34.
    Feldmann M, Corbett DB, Ramsey EJ, et al. Abnormal gastric function in longstanding insulin-dependent diabetic patients. Gastroenterology 1979;77:12–6.Google Scholar
  35. 35.
    Fischer H, Heidemann T, Hengst K, et al. Increased gastroesophageal reflux in diabetes mellitus. Gastroenterology 1998;114:A-752.Google Scholar
  36. 36.
    Fisher WE, Boros LG, O’Dorisio TM, et al. GI hormonal changes in diabetes influence pancreatic cancer growth. J Surg Res 1995;58:754–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Fortson MR, Freedman SN. Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995;90:2134–9.PubMedGoogle Scholar
  38. 38.
    Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycemia slows gastric emptying in type 1 diabetes mellitus. Diabetologia 1990;33:675–80.PubMedCrossRefGoogle Scholar
  39. 39.
    Gaber AO, Oxley D, Karas J, et al. Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis Sci 1991;9:437–43.CrossRefGoogle Scholar
  40. 40.
    GEMS Study Group. Electrical stimulation for the treatment of gastroparesis: preliminary report of a multicenter international trial. Gastroenterology 1996;110:A668.Google Scholar
  41. 41.
    Giorgino R, Damato A. Alpha-glucosidase inhibitors in the therapy of diabetes mellitus. Ann Ital Med. Int 1995;10:61S-5S.PubMedGoogle Scholar
  42. 42.
    Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. Italien Pancreatic Cancer Study Group. N Engl J Med 1994;331:81–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Hahm JS, Park JY, Park KG, et al. Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol 1996;91:2391–4.PubMedGoogle Scholar
  44. 44.
    Harris AG, O’Dorisio TM, Woltering EA, et al. Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel. Dig Dis Sci 1995;40:1464–73.PubMedCrossRefGoogle Scholar
  45. 45.
    Holtmeier W, Caspary WF. Antikörperdiagnostik bei Sprue/Zöliakie. Z Gastroenterol 1998:36:587–97.PubMedGoogle Scholar
  46. 46.
    Horowitz M, Maddox A, Harding PE, et al. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 92:1899–907.PubMedGoogle Scholar
  47. 47.
    Ishii M, Nakamura T, Kasai F, et al. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis. Diabetes Care 1997;20:1134–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Janssens J, Peters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 1990;234:1028–31.Google Scholar
  49. 49.
    Jermendy G, Fornet B, Koltai MZ, et al. Correlation between oesophageal dysmotility and cardiovascular autonomic dysfunktion in diabetic patients without gastrointestinal symptoms of autonomic neuropathy. Diabetes Res 1991;16:193–7.PubMedGoogle Scholar
  50. 50.
    Jorgensen T. Gallstones in a danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut 1989;30:5528–34.Google Scholar
  51. 51.
    Kandemir O, Utas C, Gonen O, et al. Colonic subeptithelial collagenous thickening in diabetic patients. Dis Colon Rectum 1995;38:1097–100.PubMedCrossRefGoogle Scholar
  52. 52.
    Kangas T, Aro S, Koivisto VA, et al. Structure and costs of health care in diabetic patients in Finland. Diabetes Care 1996;19:494–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Kao CH, Pan DY, Wang SL, et al. The relationship between Helicobacter pylori infection and gastric emptying in patients with non-insulin-dependent diabetes mellitus. Eur J Nucl Med 1995;22:122–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Kassander P. Symptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958;48:797–812.PubMedGoogle Scholar
  55. 55.
    Kawano T, Shigehira M, Uto H, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996;91:309–13.PubMedGoogle Scholar
  56. 56.
    Kingston ME, Ali MA, Atiyeh M, et al. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984;87:668–94.Google Scholar
  57. 57.
    Konturek JW, Dietl K-H, Domschke W. Magenschrittmacher-Implantation. Dtsch Ärztebl 1997;94:A-1511–3.Google Scholar
  58. 58.
    Kress S, Dorlars D, Buttmann A., et al. The influence of gastroparesis on gastrooesophageal reflux disease (GERD). Gastroenterology 1998;114:A188.CrossRefGoogle Scholar
  59. 59.
    La Vecchia C, D’Avanzo B, Negri E, et al. History of selected diseases and the risk of colorectal cancer. Eur J Cancer 1991;27:582–6.PubMedGoogle Scholar
  60. 60.
    La Vecchia C, Negri E, Franceschi S, et al. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994;70:950–3.PubMedGoogle Scholar
  61. 61.
    Lankisch PG, Löhr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993;54:148–55.PubMedCrossRefGoogle Scholar
  62. 62.
    Layer P. Physiologie der Motilität des oberen Gastrointestinaltraktes. In: Goebell H, Layer P, Hrsg. Störungen der Motilität des oberen Gastrointestinaltraktes. Berlin-Heidelberg: Springer 1992:1–11.Google Scholar
  63. 63.
    Lehmann R, Borovicka J, Kunz P, et al. Evaluation of delayed gastric emptying in diabetic patients with autonomic neuropathy by new magnetic resonance imaging technique and radio-opaque markers. Diabetes Care 1996;19:1075–82.PubMedCrossRefGoogle Scholar
  64. 64.
    Lerner J, Brumberger V, Praec-Mursic V. Severe diarrhea associated with Arcobacter butzleri. Eur J Clin Microbiol Infect Dis 1994;13:660–2.PubMedCrossRefGoogle Scholar
  65. 65.
    LeRoith D, Baserga R, Helman L, et al. Insulin-like growth factors and cancer. Ann Intern Med 1995;122:54–9.PubMedGoogle Scholar
  66. 66.
    Levin JA, Muzyka BC, Glick M. Dental management of patients with diabetes mellitus. Compend Contin Educ Dent 1996;17:82–6.PubMedGoogle Scholar
  67. 67.
    Levitt NS, Adams G, Salmon J, et al. The prevalence and severity of mikrovascular complications in pancreatic diabetes and IDDM. Diabetes Care 1995;18:971–4.PubMedCrossRefGoogle Scholar
  68. 68.
    Mäki M, Hallström O, Huupponen T, et al. Increased prevalence of coeliac disease in diabetes. Arch Dis Child 1984;59:739–42.PubMedCrossRefGoogle Scholar
  69. 69.
    Mann NS, Mann SK. Celiac sprue and diabetes mellitus. J Clin Gastroenterol 1993;16:4–5.PubMedGoogle Scholar
  70. 70.
    McCallum RW, Valenzuela G, Polepalle S, et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: Clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther 1991;258:136–42.PubMedGoogle Scholar
  71. 71.
    McKeown-Eyssen G. Epidemiology of colorectal cancer revisisted: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687–95.PubMedGoogle Scholar
  72. 72.
    Mearin F, Camilleri M, Malagelada JR. Pyloric dyfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986;90:1919–25.PubMedGoogle Scholar
  73. 73.
    Merio R, Festa A, Bergmann H, et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 1997;20:419–23.PubMedCrossRefGoogle Scholar
  74. 74.
    Meshkinpour H, Haghighat P, Dutton C. Clinical spectrum of esophageal aperistalsis in the elderly. Am J Gastroenterol 1994;89:1480–3.PubMedGoogle Scholar
  75. 75.
    Minocha A, Katragadda R, Rahal PS, et al. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. Aliment Pharmacol Ther 1995;9:529–33.PubMedGoogle Scholar
  76. 76.
    Morali GA, Braverman DZ, Lissi J, et al. Effect of clonidine on gallbladder contraction and small bowel transit time in insulin-treated diabetics. Am J Gastroenterol 1991; 86:995–9.PubMedGoogle Scholar
  77. 77.
    Murat A, Pouliquen B, Cantarovich D, et al. Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation. Transplant Proc 1992;24:855–8.PubMedGoogle Scholar
  78. 78.
    Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996;41:458–61.PubMedCrossRefGoogle Scholar
  79. 79.
    Ozylikan E, Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis, C virus infection. Am J Gastroenterol 1996;91:480–1.Google Scholar
  80. 80.
    Payne JE, Meyer HJ. The influence of other disease upon the outcome of colorectal cancer patients. Aust NZ J Surg 1995;65:398–402.CrossRefGoogle Scholar
  81. 81.
    Pelot D, Dana ER, Berk JE. Comparative assessment of gastric emptying by barium burger and saline load test. Am J Gastroenterol 1972;58:411–7.PubMedGoogle Scholar
  82. 82.
    Perdichizzi G, Bottari M, Pallio S, et al. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. N Microbiol 1996;19:149–54.Google Scholar
  83. 83.
    Persson GE, Thulin AJ. Prevalence of gallstone disease in patients with diabetes mellitus. A case-control study. Eur J Surg 1991;157:579–82.PubMedGoogle Scholar
  84. 84.
    Pfaffenbach B, Schaffstein J, Adamek RJ, et al. 13C-Acetat-Atemtest zur nicht-invasiven Beurteilung der Magenentleerung einer flüssig-festen Testmahlzeit bei Diabetikern. Dtsch Med Wochenschr 1996;121:713–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Pinto HC, Baptista A, Camilo ME, et al. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory, hospitalized patients. Dig Dis Sci 1996;41:172–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Porco FV, Visconte EB. Pseudomonas aeruginosa as a cause of infectious diarrhea successfully treated with oral ciprofloxacin. Ann Pharmacother 1995;29:1122–3.PubMedGoogle Scholar
  87. 87.
    Quirino MR, Birman EG, Paula CR. Oral manifestations of diabetes mellitus in controlled and uncontrolled patients. Braz Dent J 1995;6:131–6.PubMedGoogle Scholar
  88. 88.
    Rathmann W, Enck P, Frieling T, et al. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care 1991;14:1086–9.PubMedCrossRefGoogle Scholar
  89. 89.
    Ratzmann KP. Eine Analyse von alters- und geschlechtsspezifischer Diabetesprävalenz sowie Behandlungsart: die Berlin-Studie. Akt Endokrinol Stoffw 1991;12:220–3.Google Scholar
  90. 90.
    Rensch MJ, Merenich JA, Liebermann M, et al. Glutensensitive enteropathy in patients with insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:564–7.PubMedGoogle Scholar
  91. 91.
    Richards RD, Valenzuela GA, Davenport KG, et al. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis. Dig Dis Sci 1993;38:811–6.PubMedCrossRefGoogle Scholar
  92. 92.
    Rothstein RD, Alavi A. The evaluation of the patient with gastroparesis secondary to insulin dependent diabetes mellitus. J Nucl Med 1992;33:1707–9.PubMedGoogle Scholar
  93. 93.
    Samson M, Salet GA, Roelofs JM, et al. Compliance of the proximal stomach and dyspeptic symptoms in patients with type 1 diabetes mellitus. Dig Dis Sci 1995; 40:2037–42.CrossRefGoogle Scholar
  94. 94.
    Schramm H, Arnold S, Stelzer E, et al. Zur operativen Therapie der chronischen Pankreatitis. Verdauungskrankheiten 1997;15:147–53.Google Scholar
  95. 95.
    Schwartz B, Schuchat A, Oxtoby MJ, et al. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 1991;266:1112–4.PubMedCrossRefGoogle Scholar
  96. 96.
    Schwitzer W, Borovicka J, Kunz P, et al. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997;41:500–4.CrossRefGoogle Scholar
  97. 97.
    Seppaa B, Ainamo J. Dark field microscopy of the subgingival microflora in insulin-dependent diabetics. J Clin Peridontol 1996;23:63–7.CrossRefGoogle Scholar
  98. 98.
    Sidhu SS, Shah P, Prasanna BM, et al. Chronic calcific pancretitis of the tropics (CCPT): spectrum and correlates of exocrine and endocrine pancreatic dysfunction. Diabetes Res Clin Pract 1995;27:127–32.PubMedCrossRefGoogle Scholar
  99. 99.
    Sims MA, Hasler WL, Chey WD, et al. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristalitic reflexes in healthy humans. Gastroenterology 1995;108:350–9.PubMedCrossRefGoogle Scholar
  100. 100.
    Sirakov M, Trichkov V, Megdanski KH. The combination of chronic calculous cholecystitis and diabetes mellitus. Khirurgiia Sofia 1995;48:20–2.PubMedGoogle Scholar
  101. 101.
    Sjoberg K, Eriksson KF, Bredberg A, et al. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998;243:133–40.PubMedCrossRefGoogle Scholar
  102. 102.
    Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995;4:807–11.PubMedGoogle Scholar
  103. 103.
    Stremmel W, Petrides AS, Strohmeyer G. Leber und Hormone. Intern Welt 1986;9:130–9.Google Scholar
  104. 104.
    Stremmel W, Niederau C, Berger M, et al. Abnormalities in estrogen, androgen, insulin metabolism in idiopathic hemochromatosis. Ann NY Acad Sci 1988; 526:209–23.PubMedCrossRefGoogle Scholar
  105. 105.
    Takahashi T, Nakamura K, Itoh H, et al. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997;113:1535–44.PubMedCrossRefGoogle Scholar
  106. 106.
    Telzak EE, Greenberg MS, Budnick LD, et al. Diabetes mellitus-a newly described risk factor for infection from Salmonella enteritidis. J Infect Dis 1991;164:538–41.PubMedGoogle Scholar
  107. 107.
    Trevino-Perez S, Luna-Castanos G, Matilla-Matilla A, et al. Chronic diarrea and cryptosporidium in diabetic patients with normal lymphocyte subpopulation. 2 case reports. Gac Med Mex 1995;131:219–22.PubMedGoogle Scholar
  108. 108.
    Trilla A, Miro JM. Identifying high risk patients for Staphylococcus aureus infections: skin and soft tissue infections. J Chemother 1995;7:37–43.PubMedGoogle Scholar
  109. 109.
    van Houtum WH, Lavery LA, Harkless LB. The costs of diabetes-related lower extremity amputations in the Netherlands. Diabet Med 1995;12:777–81.PubMedCrossRefGoogle Scholar
  110. 110.
    Vogelberg KH, Kübler HGW. Magenentleerung und Blutglukose bei insulinpflichtigem Diabetes mellitus mit autonomer Neuropathie. Dtsch Med Wochenschr 1985;110:1249–53.PubMedCrossRefGoogle Scholar
  111. 111.
    Vogelberg KH, Kübler KGW, Cicmir J, et al. Gallenblasenkontraktilität, Cholelithiasis und autonome Neuropathie bei Diabetes mellitus. Dtsch Med Wochenschr 1984;109:1712–5.PubMedCrossRefGoogle Scholar
  112. 112.
    von der Ohe MR, Hanson RB, Camilleri M. Serotonic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994;35:536–41.PubMedCrossRefGoogle Scholar
  113. 113.
    von der Ohe, MR. Diarrhea in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995;7:730–6.PubMedGoogle Scholar
  114. 114.
    von der Ohe MR. Pathophysiologie von Motilitätsstörungen im oberen Gastrointestinaltraktes. In: Goebell H, Layer P, Hrsg. Störungen der Motilität des oberen Gastrointestinaltraktes. Berlin-Heidelberg. Springer, 1992:13–31.Google Scholar
  115. 115.
    Wald A, Tunuguntlar AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med 1984;310:1282–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Wanless IR, Esposti JS, Lentz L. Fatty liver hepatitis (Steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106–10.PubMedCrossRefGoogle Scholar
  117. 117.
    Wegener M, Schaffstein J, Börsch G. Physiologie und Pathophysiologie der Magenentleerung. Grundlagen, Untersuchungsmethoden und Therapie. Med Klin 1988;53:335–41.Google Scholar
  118. 118.
    Wilson IR, Hurrell MA, Pattinson NR, et al. The effect of simvastatin and bezafibrate on bile composition and gall-blader emptying in female non-insulin-dependent diabetics. J Gastroenterol Hepatol 1994;9:447–51.PubMedCrossRefGoogle Scholar
  119. 119.
    Zehr PS, Milde FK, Hart LK, et al. Pancres transplantation: assessing secondary complications and life quality. Diabetologia 1991;34:138–40.CrossRefGoogle Scholar
  120. 120.
    Ziegler D, Schadewaldt P, Pour Mirza A, et al. [13C]-octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 1996;39:823–30.PubMedCrossRefGoogle Scholar

Copyright information

© Urban & Vogel 1999

Authors and Affiliations

  • Michael Vogt
    • 1
  • Henning E. Adamek
    • 1
  • Joachim C. Arnold
    • 1
  • Dieter Schilling
    • 1
  • Thomas Schleiffer
    • 1
  • Jürgen F. Riemann
    • 1
  1. 1.Gastroenterologie, Hepatologie, Infektionskrankheiten, DiabetologieMedizinische Klinik C, Klinikum Ludwigshafen gGmbHLudwigshafen am Rhein

Personalised recommendations